Nuclear medicine and biology
Journal
Overview
publication venue for
-
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors..
136-137.
2024
-
Transcatheter pseudo-vascular isolation for localization and concentration of a large molecule theranostic probe into a transgenic OncoPIG kidney tumor..
136-137.
2024
-
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer..
114-115.
2022
-
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation..
86-87.
2020
-
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue..
84-85.
2020
-
Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging..
84-85.
2020
-
Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer..
80-81.
2019
-
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals..
71.
2019
-
[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4..
60.
2018
-
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3..
55.
2017
-
Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies..
53.
2017
-
Copper-64 labeled liposomes for imaging bone marrow..
43.
2016
-
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y..
43.
2016
-
Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas..
43.
2016
-
Synthesis of [11C]palmitic acid for PET imaging using a single molecular sieve 13X cartridge for reagent trapping, radiolabeling and selective purification..
42.
2015
-
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution..
42.
2014
-
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients..
41.
2014
-
Influence of free fatty acids on glucose uptake in prostate cancer cells..
41.
2013
-
Antilipolytic drug boosts glucose metabolism in prostate cancer..
40.
2013
-
An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides..
39.
2012
-
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer..
38.
2011
-
Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU)..
37.
2010
-
In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression..
36.
2009
-
Standardized methods for the production of high specific-activity zirconium-89..
36.
2009
-
Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?.
36.
2009
-
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity..
36.
2009
-
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH..
36.
2009
-
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer..
35.
2008
-
Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F]fluoroethoxyestradiol for positron emission tomography..
35.
2008
-
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies..
35.
2008
-
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV..
35.
2008
-
Chemosorption of radiometals of interest to nuclear medicine by synthetic melanins..
35.
2008
-
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines..
35.
2008
-
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003..
35.
2008
-
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma..
34.
2007
-
Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice..
34.
2007
-
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides..
33.
2006
-
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors..
33.
2006
-
Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil..
32.
2005
-
Preparation of high specific activity (86)Y using a small biomedical cyclotron..
32.
2005
-
Breast imaging: a surgeon's prospective..
32.
2005
-
Measurement of input functions in rodents: challenges and solutions..
32.
2005
-
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM..
32.
2005
-
Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors..
32.
2005
-
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors..
32.
2005
-
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents..
32.
2005
-
Basic characterization of 64Cu-ATSM as a radiotherapy agent..
32.
2005
-
Semi-automated 86Y purification using a three-column system..
31.
2004
-
Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET..
31.
2004
-
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals..
30.
2003
-
Synthesis of dendrimer-based biotin radiopharmaceuticals to enhance whole-body clearance..
30.
2003
-
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG..
30.
2003
-
Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagents..
29.
2002
-
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter..
29.
2002
-
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors..
29.
2002
-
Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications..
29.
2002
-
Synthesis and characterization of (99m)Tc- and (188)Re-complexes with a diamido-dihydroxymethylenephosphine-based bifunctional chelating agent (N(2)P(2)-BFCA)..
29.
2002
-
Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides..
28.
2001
-
High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T..
26.
1999
-
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors..
26.
1999
-
High purity production and potential applications of copper-60 and copper-61..
26.
1999
-
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake..
26.
1999
-
Evaluation of 99mTc-mercaptoacetyltriglycine-biocytin as a new hepatobiliary imaging agent in mice coinjected with bilirubin..
26.
1999
-
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography..
26.
1999
-
Use of 99mTc-mercaptoacetyltriglycine (MAG3)-biocytin hepatobiliary scintigraphy to study the protective effect of a synthetic enzyme inhibitor on acute hepatotoxicity in mice..
25.
1998
-
Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment..
25.
1998
-
Biodistribution of [64Cu]Cu2+ and variance of metallothionein during tumor treatment by copper..
25.
1998
-
In vitro and in vivo evaluation of structure-stability relationship of 111In- and 67Ga-labeled antibody via 1B4M or C-NOTA chelates..
24.
1997
-
Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography..
23.
1996
-
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses..
23.
1996
-
In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody..
22.
1995
-
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies..
22.
1995
-
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results..
22.
1995
-
Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model..
22.
1995
-
Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution..
21.
1994
-
Current status of radioimmunodetection..
21.
1994
-
Current status of radioimmunotherapy..
21.
1994
-
Gallium-67-citrate imaging in nuclear oncology..
21.
1994
-
Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen..
21.
1994
-
Evaluation of a new DTPA-derivative chelator: comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts..
20.
1993
-
G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiation..
20.
1993
-
Human reporter genes: potential use in clinical studies.
2007
-
Reporter gene imaging: potential impact on therapy.
2005
-
PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
2012
-
Copper radionuclides and radiopharmaceuticals in nuclear medicine.
1996
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)